Skip to main content
DFNS
NASDAQ Trade & Services

T3 Defense Shareholders Approve Dilutive Conversions and Reverse Stock Split Authority

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
8
Price
$0.171
Mkt Cap
$16.444M
52W Low
$0.164
52W High
$15.59
52W Position info
4.4% above low
Off High info
99% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

DFNS is trading near its 52-week low of $0.164 (4.4% above the low).

Summary

T3 Defense shareholders approved key proposals, including dilutive warrant and preferred stock conversions for Nasdaq compliance, and granted the Board authority for a reverse stock split to address minimum bid price issues.


Key Events · Corporate Governance and Compliance · DFNS

  • Shareholder Approval for Dilutive Conversions

    Stockholders approved the issuance of common stock from warrant exercises and preferred stock conversions related to a February 2026 private placement, necessary for Nasdaq compliance. This follows the PRE 14A filed on April 14, 2026, which outlined these highly dilutive proposals.

  • Board Granted Reverse Stock Split Authority

    The Board now has discretionary authority for 18 months to implement a reverse stock split, with a ratio between 1-for-2 and 1-for-250. This action is intended to address the Nasdaq minimum bid price requirement, following a non-compliance notice received on May 8, 2026.

  • Critical for Nasdaq Compliance and Operations

    These approvals are crucial steps for T3 Defense Inc. to address its Nasdaq listing deficiencies and continue its operations amidst a 'going concern' warning and trading near its 52-week low.


Analysis · DFNS · Trade & Services

Shareholders approved the issuance of common stock from a February 2026 private placement, which includes warrant exercises and preferred stock conversions, to comply with Nasdaq rules. Additionally, the Board was granted authority to implement a reverse stock split (up to 1:250) to address the Nasdaq minimum bid price deficiency. These approvals are critical for the company to maintain its Nasdaq listing and secure necessary capital, despite the significant potential for dilution and the negative perception often associated with reverse stock splits, especially as the company trades near its 52-week low.

At the time of this filing, DFNS was trading at $0.17 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $16.4M. The 52-week trading range was $0.16 to $15.59. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DFNS - Latest Insights

DFNS
Aug 07, 2026, 11:01 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $39.46
Real-time Price: $36.00 info
Change: -$3.46 (-9%) info
Market Cap: $37.217M info
DFNS
Aug 03, 2026, 10:27 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $47.49
Real-time Price: $36.00 info
Change: -$11.49 (-24%) info
Market Cap: $37.217M info
DFNS
Jul 31, 2026, 10:39 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $35.98
Real-time Price: $36.00 info
Change: +$0.0176 (+0.05%) info
Market Cap: $37.217M info
DFNS
Jul 24, 2026, 5:20 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $4.46
Real-time Price: $36.00 info
Change: +$31.54 (+707%) info
Market Cap: $37.217M info
DFNS
Jul 16, 2026, 10:23 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.063709
Real-time Price: $36.00 info
Change: Reverse Stock Split info
Market Cap: $37.217M info